SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0000891293-19-000031
Filing Date
2019-04-17
Accepted
2019-04-17 08:38:15
Documents
1
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 DEFR14A ctic-2019proxystatementame.htm DEFR14A 37933
  Complete submission text file 0000891293-19-000031.txt   39039
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-28386 | Film No.: 19752257
SIC: 2834 Pharmaceutical Preparations